查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
分离术的全球市场:预测(2022年～2028年)
市场调查报告书
商品编码
1123262

分离术的全球市场:预测(2022年～2028年)

Global Hemapheresis Market Research and Forecast, 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

全球分离术的市场规模，预计从2021年到2027年之间，以约6.8％的年复合成长率成长。促进市场成长的主要原因，是慢性疾病增加，血浆的需求增加，复杂的手术增加，血液安全性的认识和关心的高涨，血液成分的需求增加，公共、私人的资金提供等。同时，高安装成本，及血液透析机设备和治疗相关的成本等，有抑制市场成长的可能性。

本报告提供全球分离术市场调查，市场概要，市场的推动因素与阻碍因素的分析，各技术、产品、手术、用途、地区的分析，竞争情形，再加上主要企业的简介等全面性资讯。

目录

第1章 报告概要

第2章 市场概要与洞察

  • 调查范围
  • 分析师的洞察和目前市场趋势

第3章 竞争情形

  • 主要企业分析
    • 概要
    • 财务分析
    • SWOT分析
    • 最近的开发
  • 主要策略分析
  • COVID-19对主要企业的影响

第4章 市场决策要素

  • 促进因素
  • 阻碍因素
  • 机会

第5章 市场区隔

  • 全球分离术市场:各技术
    • 离心分离
    • 膜分离技术
    • 选择性吸着
  • 全球分离术市场:各产品
    • 设备
    • 抛弃式
  • 全球分离术市场:各手术
    • 体外光照疗法
    • 血浆清除术
    • 血小板血球分离术
    • 白血球血球分离术
    • 红血球血球分离术
    • 其他
  • 全球分离术市场:各用途
    • 血液学
    • 神经学
    • 肾臟疾病
    • 其他(自体免疫疾病)

第6章 地区分析

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 其他的欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他的亚太地区
  • 其他地区
    • 南美
    • 中东、非洲

第7章 企业简介

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Cerus Corp.
  • Fenwal, Inc.
  • Fresenius Medical Care AG & Co. KGaA.
  • Haemonetics Corp.
  • HemaCare Corp.
  • Kaneka Corp.
  • Kawasumi Laboratories, Inc.
  • Medica S.P.A
  • Nikkiso Co. Ltd.
  • Novelion Therapeutics Inc.(Alvarez & Marsal Holdings, LLC)
  • Sichuan Nigale Biomedical Co., Ltd.
  • Sorin Group(LivaNova PLC)
  • Terumo BCT, Inc.
  • Therakos Inc.
Product Code: OMR2018430

Global Hemapheresis Market Size, Share & Trends Analysis Report By Technology (Centrifugation, Membrane Separation, and Selective Adsorption) By Product (Devices, and Disposable) By Procedure (Photopheresis, Plasmapheresis, and Others) By Application (Hematology, Neurology, and Others) Forecast, 2021-2027

The global hemapheresis market is anticipated to grow at a CAGR of around 6.8% during the forecast period (2021-2027). Hemapheresis is a medical procedure that involves removing whole blood from a donor's body for separating and analyzing the individual components of the blood so that desired blood component can be removed. It generally works based on two common techniques known as membrane separation and centrifugation. This procedure is used for the collection of the blood components namely, plasma and platelets. It is also widely used for the treatment of neurological disorders, blood disorders, cardiovascular disorders, and several other blood-related disorders. Hemapheresis procedures are performed across hospitals and blood collection centers.

The global hemapheresis market is estimated to grow at a significant rate during the forecast period owing to the increasing prevalence of chronic diseases across the globe and growing demand for plasma in the pharmaceuticals and biotechnology companies for the development of plasma-derived medicines. Further, the increasing number of complex surgeries, increasing awareness and concern for blood safety and growing demand for blood components, and public and private funding are also estimated to be the major factors that are driving the growth of the market. Moreover, the cost associated with hemapheresis devices and therapeutic procedures, high installation cost, and lack of awareness about blood donation via hemapheresis procedure are the factors expected to hamper the growth of the market during the forecast period.

Segmental Outlook

The global hemapheresis market is segmented based on technology, product, procedure, and application. Based on technology, the market is classified into centrifugation, membrane separation, and selective adsorption. Among these, the centrifugation technology segment is projected to grow at the highest CAGR during the forecast period owing to the advantages and higher efficiency provided by the technology during blood separation. Based on the product, the market is bifurcated into hemapheresis devices and hemapheresis disposables. The hemapheresis disposables segment held the major share in 2020, and it is projected to dominate the market during the forecast period owing to the increased purchase of hemapheresis kits due to increased long-term purchase contact between manufacturers and end-users. Based on procedure, the market is segregated into photopheresis, plasmapheresis, plateletpheresis, leukapheresis, erythrocytapheresis, and others. Whereas, based on application, the market is divided into hematology, neurology, renal diseases, and others (autoimmune disorder).

Global Hemapheresis Market Share by Procedure, 2020 (%)

Global Hemapheresis Market Share by Procedure

The photopheresis segment is projected to grow at a significant rate in the global hemapheresis market

Among the procedure segment, the photopheresis is projected to grow at a significant rate during the forecast period. The segment dominated the market by accounting highest share in 2020, and it is further anticipated to dominate during the forecast period. The segmental growth is mainly attributed to the increased blood disorders that have accelerated the demand for blood plasma. Photopheresis is one of the treatments for organ transplant rejection. In addition, the treatment also possesses several advantages during blood separation. With increased blood disorder, the adoption of photopheresis treatment has increased and it is estimated that during the forecast period, the segment will grow more with increasing requirements for blood plasma. Which in turn, drives the growth of the market.

Regional Outlook

Geographically, the global hemapheresis market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, ASEAN, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). North America is estimated to hold a significant share owing to the high prevalence rate of chronic diseases in the region and well-established healthcare infrastructure. The US holds the largest share in the global hemapheresis market owing to the continuous advancement in technology, and the presence of the largest patient pool affected with suffering from various chronic diseases that have spurred the market growth. Moreover, the presence of major players and their continued efforts for new device and technology developments has also accelerated the market growth.

Global Hemapheresis Market Growth, By Region 2021-2027

Global Hemapheresis Market Growth, By Region

Asia-Pacific is projected to be the Fastest Growing Region in the Global Hemapheresis Market

Geographically, Asia-Pacific is anticipated to grow at the fastest CAGR during the forecast period. In Asia-Pacific, China, India, and Japan, and the rest of Asia-Pacific are the major economies that are contributing towards the regional growth. The increasing geriatric population, chronic diseases and rapidly increasing healthcare expenditure is the prominent factors driving the growth of the market. China is the major contributor to the hemapheresis market, owing to the increasing use of blood plasma in various treatments. In addition, the healthcare sector in China is also growing at a rapid pace due to advanced healthcare reforms. China is one of the largest manufacturers or consumers in the plasma-derived product market. Many organizations in China ensure a steady, self-sufficient, and safe supply of reliable plasma-derived products, and these organizations also encourage people to donate more. The increasing geriatric population with numerous chronic diseases is anticipated to drive the demand for hemapheresis devices and disposables during the forecast period.

Market Players Outlook

The key players in the hemapheresis market contributing significantly by providing different types of products and increasing their geographical presence across the globe. The key players of the market include Asahi Kasei Medical Co., Ltd., Baxter International Inc., Cerus Corp, Fresenius Medical Care AG & Co. KGaA., Haemonetics Corp, Kaneka Corp, Kawasumi Laboratories, Inc., among others. These market players are adopting several market strategies including product launch and approvals, merger and acquisition, partnership collaboration, business, and capacity expansion, and others. For instance, in April 2021, Asahi Kasei Medical announced that it has expanded its business in virus filtration, with its Planova in China through its subsidiary Asahi Kasei Bioprocess (Shanghai) Co., Ltd. (AKBC). The company expanded its business intending to reinforce its global supply infrastructure for Planova to support the early provision of coronavirus vaccines and therapies to as many people as possible.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global hemapheresis market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Hemapheresis Industry
  • Recovery Scenario of Global Hemapheresis Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on key players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Hemapheresis Market, By Technology
    • 5.1.1. Centrifugation
    • 5.1.2. Membrane Separation
    • 5.1.3. Selective Adsorption
  • 5.2. Global Hemapheresis Market, By Product
    • 5.2.1. Hemapheresis Devices
    • 5.2.2. Hemapheresis Disposables
  • 5.3. Global Hemapheresis Market, By Procedure
    • 5.3.1. Photopheresis
    • 5.3.2. Plasmapheresis
    • 5.3.3. Plateletpheresis
    • 5.3.4. Leukapheresis
    • 5.3.5. Erythrocytapheresis
    • 5.3.6. Others
  • 5.4. Global Hemapheresis Market, By Application
    • 5.4.1. Hematology
    • 5.4.2. Neurology
    • 5.4.3. Renal Disease
    • 5.4.4. Others (Autoimmune Disorder)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World
    • 6.4.1. Latin America
    • 6.4.2. Middle East & Africa

7. Company Profiles

  • 7.1. Asahi Kasei Medical Co., Ltd.
  • 7.2. B. Braun Melsungen AG
  • 7.3. Baxter International Inc.
  • 7.4. Cerus Corp.
  • 7.5. Fenwal, Inc.
  • 7.6. Fresenius Medical Care AG & Co. KGaA.
  • 7.7. Haemonetics Corp.
  • 7.8. HemaCare Corp.
  • 7.9. Kaneka Corp.
  • 7.10. Kawasumi Laboratories, Inc.
  • 7.11. Medica S.P.A
  • 7.12. Nikkiso Co. Ltd.
  • 7.13. Novelion Therapeutics Inc. (Alvarez & Marsal Holdings, LLC)
  • 7.14. Sichuan Nigale Biomedical Co., Ltd.
  • 7.15. Sorin Group (LivaNova PLC)
  • 7.16. Terumo BCT, Inc.
  • 7.17. Therakos Inc.

LIST OF TABLES

  • 1. GLOBAL HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 2. GLOBAL CENTRIFUGATION MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL MEMBRANE SEPARATION MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 5. GLOBAL HEMAPHERESIS DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL HEMAPHERESIS DISPOSABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION)
  • 8. GLOBAL PHOTOPHERESIS IN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL PLASMAPHERESIS IN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL PLATELETPHERESIS IN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL LEUKAPHERESIS IN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL ERYTHROCYTAPHERESIS IN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL HEMAPHERESIS IN OTHERS PROCEDURE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 15. GLOBAL HEMAPHERESIS IN HEMATOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL HEMAPHERESIS IN NEUROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 17. GLOBAL HEMAPHERESIS IN RENAL DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 18. GLOBAL HEMAPHERESIS IN OTHERS (AUTOIMMUNE DISORDER)MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 19. NORTH AMERICAN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 20. NORTH AMERICAN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 21. NORTH AMERICAN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BYPRODUCT, 2020-2027 ($ MILLION)
  • 22. NORTH AMERICAN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION)
  • 23. NORTH AMERICAN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 24. EUROPEAN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 25. EUROPEAN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 26. EUROPEAN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BYPRODUCT, 2020-2027 ($ MILLION)

27. EUROPEAN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION

28. EUROPEAN HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION

  • 29. ASIA-PACIFIC HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 30. ASIA-PACIFIC HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY,2020-2027 ($ MILLION)
  • 31. ASIA-PACIFIC HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BYPRODUCT, 2020-2027 ($ MILLION)
  • 32. ASIA-PACIFIC HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION)
  • 33. ASIA-PACIFIC HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
  • 34. REST OF THE WORLD HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 35. REST OF THE WORLD HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 36. REST OF THE WORLD HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 37. REST OF THE WORLD HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION)
  • 38. REST OF THE WORLD HEMAPHERESIS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)

LIST OF FIGURES

1. IMPACT OF COVID-19 ON GLOBAL HEMAPHERESIS MARKET, 2020-2027 (% MILLION)

2. IMPACT OF COVID-19 ON GLOBAL HEMAPHERESIS MARKET BY SEGMENT, 2020-2027 (% MILLION)

  • 3. RECOVERY OF GLOBAL HEMAPHERESIS MARKET, 2020-2027 (%)
  • 4. GLOBAL HEMAPHERESIS MARKET SHARE BY TECHNOLOGY,2020 VS 2027 (%)
  • 5. GLOBAL HEMAPHERESIS MARKET SHARE BY PRODUCT, 2020 VS 2027 (%)
  • 6. GLOBAL HEMAPHERESIS MARKET SHARE BY PROCEDURE, 2020 VS 2027 (%)
  • 7. GLOBAL HEMAPHERESIS MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
  • 8. GLOBAL HEMAPHERESIS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBAL CENTRIFUGATION MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL MEMBRANE SEPARATION MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL HEMAPHERESIS DEVICES MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL HEMAPHERESIS DISPOSABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL PHOTOPHERESIS IN HEMAPHERESIS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL PLASMAPHERESIS IN HEMAPHERESIS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL PLATELETPHERESIS IN HEMAPHERESIS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL LEUKAPHERESIS IN HEMAPHERESIS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 17. GLOBAL ERYTHROCYTAPHERESIS IN HEMAPHERESIS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 18. GLOBAL HEMAPHERESIS IN OTHERS PROCEDURE MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 19. GLOBAL HEMAPHERESIS IN HEMATOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 20. GLOBAL HEMAPHERESIS IN NEUROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 21. GLOBAL HEMAPHERESIS IN RENAL DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 22. GLOBAL HEMAPHERESIS IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 23. US HEMAPHERESIS MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. CANADA HEMAPHERESIS MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. UK HEMAPHERESIS MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. FRANCE HEMAPHERESIS MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. GERMANY HEMAPHERESIS MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. ITALY HEMAPHERESIS MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. SPAIN HEMAPHERESIS MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. REST OF EUROPE HEMAPHERESIS MARKET SIZE, 2020-2027 ($ MILLION)
  • 31. INDIA HEMAPHERESIS MARKET SIZE, 2020-2027 ($ MILLION)
  • 32. CHINA HEMAPHERESIS MARKET SIZE, 2020-2027 ($ MILLION)
  • 33. JAPAN HEMAPHERESIS MARKET SIZE, 2020-2027 ($ MILLION)
  • 34. SOUTH KOREA HEMAPHERESIS MARKET SIZE, 2020-2027 ($ MILLION)
  • 35. REST OF ASIA-PACIFIC HEMAPHERESIS MARKET SIZE, 2020-2027 ($ MILLION)

36. REST OF THE WORLD HEMAPHERESIS MARKET SIZE, 2021-2027($ MILLION